Path Traversal in Spinetix Diva
CVE-2020-15809
spxmanage on certain SpinetiX devices allows requests that access unintended resources because of SSRF and Path Traversal. This affects HMP350, HMP300, and DiVA through 4.5.2-1.0.36229; HMP400 and HMP400W through 4.5.2-1.0.2-1eb2ffbd; and DSOS through 4.5.2-1.0.2-1eb2ffbd.
Vulnerability class: Path Traversal (Directory Traversal)
EPSS: 0.009 (57.3th percentile) — read the EPSS interpretation.
CVSS v3 metric
CVSS v3 base score 6.5 (Medium). Vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N.
Affected products
Weakness classification (CWE)
References
- cve@mitre.org (x_refsource_MISC, Release Notes, Vendor Advisory)
- cve@mitre.org (x_refsource_MISC, Release Notes, Vendor Advisory)
Frequently asked questions
- What is CVE-2020-15809?
- CVE-2020-15809 is a medium-severity vulnerability in Spinetix Diva, classified under Path Traversal. CVSS score: 6.5/10. Published 2021-03-24.
- How severe is CVE-2020-15809?
- Medium severity. CVSS v3 base score is 6.5 out of 10.